For years, veterans have reported serious, sometimes permanent, adverse reactions to the anti-malaria drug mefloquine. But a recently released report from the Australian Senate finds no link ...

"Mefloquine causes toxic brain injury," says Dr. Remington Nevin, a former Army doctor, who's now with the Johns Hopkins School of Public Health. Elite Army units to stop taking anti-malaria drug.

Objective: To compare the efficacy and tolerability of mefloquine and proguanil in malaria prophylaxis in sickle cell anaemia. Design: Nonblind, prospective, multicentre study. Participants: The ...

In 2013, the Food and Drug Administration placed a "black box" warning on mefloquine, saying the drug can cause ongoing or permanent neurological and psychiatric conditions, including dizziness ...

Thus, to bolster mefloquine's anti-viral activity, the scientists looked into the possibility of combining it with a drug that inhibits the replication step of SARS-CoV-2: Nelfinavir.

Mefloquine, developed by the Army in the 1970s, has long been linked to disturbing neurological and psychiatric side effects. In July 2013, the U.S. Food and Drug Administration (FDA) even revised ...

The antimalarial drug mefloquine is more effective than the currently recommended treatment to prevent malaria infection in pregnant women living in endemic countries of sub-Saharan Africa, but ...

Researchers from LSTM Cochrane Infectious Diseases Group publish two systematic reviews this week about the safety of mefloquine (Lariam) for preventing malaria in travellers.

This study constitutes the first documented experience with mefloquine in this very important subgroup. Based on the results, we can conclude that malaria chemoprophylaxis with a weekly dose of ...